{"title":"Hybrid nerve sheath tumor of the spinal canal and neurofibromatosis-2, where the twain shall meet-a case report and review of literature.","authors":"Deepak Nayak Manel, Shivam Thaker, Geetha Vasudevan, Girish Menon","doi":"10.1186/s13256-025-05083-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A hybrid nerve sheath tumor is a biphasic, benign neoplasm of peripheral nerve sheaths, consisting of combinations of neurofibroma, schwannoma, or perineurioma. These tumors were recognized only recently, in 2013; they commonly occur sporadically but rarely with syndromic associations, such as neurofibromatosis syndrome, Carney complex, and schwannomatosis. With an occurrence of 1 in every 33,000 individuals, neurofibromatosis type 2 is a rare autosomal dominant condition characterized by bilateral vestibular schwannomas. Herein we report a serendipitous occurrence of a hybrid nerve sheath tumor with neurofibromatosis type 2 syndrome, with an emphasis on its diagnostic mimics.</p><p><strong>Case report: </strong>A 35-year-old Indian male patient presented to the clinic with balance dysfunction, left-sided hearing loss, and spastic weakness in all four limbs during the past 6 months. Neurological examination revealed increased motor tone in all four limbs, bilateral 4/5 limb strength, a right grip strength of 80%, and a left grip strength of 90%. Romberg's sign, Babinski sign (extensor), and Hoffman's sign were positive. No cerebellar signs were elicited. A cranial nerve examination revealed bilateral hearing impairment, with hearing of the left being greater than that of the right. Magnetic resonance imaging revealed, an ependymoma at C1-2, a hyperintensive T2 lesion (likely a meningioma), a neurofibroma at C2, and bilateral vestibular schwannomas at the cerebellopontine angle. The patient underwent tumor excision surgery under somatosensory evoked potential/motor evoked potential monitoring. The tumor at the C2 level showed a nodular arrangement with typical schwannian nodules (SOX-10 strongly positive and epithelial membrane antigen negative); these nodules were encased by a hypocellular neurofibroma component (CD34<sup>+</sup>), forming a lattice around the former. No necrosis or increased proliferation index was noted.</p><p><strong>Conclusion: </strong>Neurofibromatosis type 2 syndrome is a rare condition, associated with mutations in both alleles of the NF2 (Merlin) gene, and is associated with meningiomas and ependymomas, as seen in this patient. Its occurrence alongside a spinal hybrid nerve sheath tumor is rare and can often lead to an erroneous diagnosis of other nerve sheath tumors or, rarely, a malignant nerve sheath tumor. This case highlights this rare confluence and its mimickers.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"19 1","pages":"78"},"PeriodicalIF":0.9000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11866880/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13256-025-05083-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Hybrid nerve sheath tumor of the spinal canal and neurofibromatosis-2, where the twain shall meet-a case report and review of literature.
Background: A hybrid nerve sheath tumor is a biphasic, benign neoplasm of peripheral nerve sheaths, consisting of combinations of neurofibroma, schwannoma, or perineurioma. These tumors were recognized only recently, in 2013; they commonly occur sporadically but rarely with syndromic associations, such as neurofibromatosis syndrome, Carney complex, and schwannomatosis. With an occurrence of 1 in every 33,000 individuals, neurofibromatosis type 2 is a rare autosomal dominant condition characterized by bilateral vestibular schwannomas. Herein we report a serendipitous occurrence of a hybrid nerve sheath tumor with neurofibromatosis type 2 syndrome, with an emphasis on its diagnostic mimics.
Case report: A 35-year-old Indian male patient presented to the clinic with balance dysfunction, left-sided hearing loss, and spastic weakness in all four limbs during the past 6 months. Neurological examination revealed increased motor tone in all four limbs, bilateral 4/5 limb strength, a right grip strength of 80%, and a left grip strength of 90%. Romberg's sign, Babinski sign (extensor), and Hoffman's sign were positive. No cerebellar signs were elicited. A cranial nerve examination revealed bilateral hearing impairment, with hearing of the left being greater than that of the right. Magnetic resonance imaging revealed, an ependymoma at C1-2, a hyperintensive T2 lesion (likely a meningioma), a neurofibroma at C2, and bilateral vestibular schwannomas at the cerebellopontine angle. The patient underwent tumor excision surgery under somatosensory evoked potential/motor evoked potential monitoring. The tumor at the C2 level showed a nodular arrangement with typical schwannian nodules (SOX-10 strongly positive and epithelial membrane antigen negative); these nodules were encased by a hypocellular neurofibroma component (CD34+), forming a lattice around the former. No necrosis or increased proliferation index was noted.
Conclusion: Neurofibromatosis type 2 syndrome is a rare condition, associated with mutations in both alleles of the NF2 (Merlin) gene, and is associated with meningiomas and ependymomas, as seen in this patient. Its occurrence alongside a spinal hybrid nerve sheath tumor is rare and can often lead to an erroneous diagnosis of other nerve sheath tumors or, rarely, a malignant nerve sheath tumor. This case highlights this rare confluence and its mimickers.
期刊介绍:
JMCR is an open access, peer-reviewed online journal that will consider any original case report that expands the field of general medical knowledge. Reports should show one of the following: 1. Unreported or unusual side effects or adverse interactions involving medications 2. Unexpected or unusual presentations of a disease 3. New associations or variations in disease processes 4. Presentations, diagnoses and/or management of new and emerging diseases 5. An unexpected association between diseases or symptoms 6. An unexpected event in the course of observing or treating a patient 7. Findings that shed new light on the possible pathogenesis of a disease or an adverse effect